204 related articles for article (PubMed ID: 30840200)
1. Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children.
Thompson EJ; Wu H; Maharaj A; Edginton AN; Balevic SJ; Cobbaert M; Cunningham AP; Hornik CP; Cohen-Wolkowiez M
Clin Pharmacokinet; 2019 Jul; 58(7):887-898. PubMed ID: 30840200
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
[TBL] [Abstract][Full Text] [Related]
3. External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole.
Wu YSS; Cohen-Wolkowiez M; Hornik CP; Gerhart JG; Autmizguine J; Cobbaert M; Gonzalez D;
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0214920. PubMed ID: 33903114
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.
Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D;
Br J Clin Pharmacol; 2017 Dec; 83(12):2729-2740. PubMed ID: 28800382
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
7. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
9. Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.
Hornik CP; Wu H; Edginton AN; Watt K; Cohen-Wolkowiez M; Gonzalez D
Clin Pharmacokinet; 2017 Nov; 56(11):1343-1353. PubMed ID: 28290120
[TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations.
Clajus C; Kühn-Velten WN; Schmidt JJ; Lorenzen JM; Pietsch D; Beutel G; Kielstein JT
BMC Pharmacol Toxicol; 2013 Apr; 14():19. PubMed ID: 23551893
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
12. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
13. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
[TBL] [Abstract][Full Text] [Related]
15. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
16. A reversed-phase high-performance liquid chromatography method for the determination of cotrimoxazole (trimethoprim/ sulphamethoxazole) in children treated for malaria.
Rønn AM; Mutabingwa TK; Kreisby S; Angelo HR; Fuursted K; Bygbjerg IC
Ther Drug Monit; 1999 Dec; 21(6):609-14. PubMed ID: 10604820
[TBL] [Abstract][Full Text] [Related]
17. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.
Ferrazzini G; Klein J; Sulh H; Chung D; Griesbrecht E; Koren G
J Pediatr; 1990 Nov; 117(5):823-6. PubMed ID: 2231218
[TBL] [Abstract][Full Text] [Related]
18. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
19. Kinetic effects of trimethoprim-sulfamethoxazole in children with biliary atresia: a new dosing regimen.
Lares-Asseff I; Villegas F; Pérez G; Toledo A; Camacho A; López DC
Arch Med Res; 1996; 27(2):183-90. PubMed ID: 8696062
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections.
McDaniel LM; Fiawoo S; Tamma PD; Same RG
J Pediatric Infect Dis Soc; 2023 Oct; 12(10):534-539. PubMed ID: 37757866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
